scholarly article | Q13442814 |
P356 | DOI | 10.1155/2009/417197 |
P8608 | Fatcat ID | release_rs2onwoqcndojikkftckxj3jae |
P932 | PMC publication ID | 2809431 |
P698 | PubMed publication ID | 20111625 |
P5875 | ResearchGate publication ID | 41174903 |
P50 | author | Valentina Masola | Q30513702 |
P2093 | author name string | Nadia Gabellini | |
P2860 | cites work | A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors | Q22008633 |
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 | Q24317677 | ||
Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features | Q24643177 | ||
Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene | Q28181613 | ||
A common protein interaction domain links two recently identified epilepsy genes | Q28208508 | ||
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis | Q28213522 | ||
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy | Q28215907 | ||
The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders | Q28221371 | ||
LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway | Q28253059 | ||
Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission | Q28264840 | ||
Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. | Q52519691 | ||
Apoptosis during breast carcinoma progression | Q74484382 | ||
The leucine-rich repeat: a versatile binding motif | Q28305186 | ||
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 | ||
ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy | Q28506819 | ||
The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1 | Q28567361 | ||
The Bcl2 family: regulators of the cellular life-or-death switch | Q29614982 | ||
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product | Q29618372 | ||
Resistance to induced apoptosis in the human neuroblastoma cell line SK-N-SH in relation to neuronal differentiation. Role of Bcl-2 protein family | Q32081365 | ||
Alterations in Barrett's-related adenocarcinomas: a proteomic approach | Q33305454 | ||
Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53 | Q33883959 | ||
Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway | Q34278037 | ||
Regulation of granulocyte apoptosis by phosphatidylinositol 3-kinase | Q35780479 | ||
Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance | Q36431172 | ||
Nucleotide sequences of cDNAs for human papillomavirus type 18 transcripts in HeLa cells | Q36866757 | ||
Somatic alterations in brain tumors. | Q37601750 | ||
Defining the expression pattern of the LGI1 gene in BAC transgenic mice | Q40120626 | ||
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. | Q40308327 | ||
Antisense BAG-1 sensitizes HeLa cells to apoptosis by multiple pathways | Q40606537 | ||
Negative regulation of bcl-2 expression by p53 in hematopoietic cells | Q40811024 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 417197 | |
P577 | publication date | 2009-10-07 | |
P1433 | published in | International Journal of Cell Biology | Q26842205 |
P1476 | title | Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells | |
P478 | volume | 2009 |
Q36926842 | Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer | cites work | P2860 |
Search more.